Healthcare / Medical Care FacilitiesThailand
$0.92
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $38.5M · quality 68.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
50/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
12/100
SEC 0%
Sin guardar todavía.
Market Cap
$515M
P/E
92.0x
↑EV/EBITDA
6.3x
↓ROE
7.3%
↑Gross Margin
27.6%
↓Debt/Equity
0.21
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2025 · 2 años de histórico normalizado
Revenue CAGR
-6.3%
FCF CAGR
-31.0%
FCF margin
8.3%
FCF / Net income
1.75x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $463.1M · net income $22.0M · FCF $38.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $463.1M | $463.1M | $492.5M | $527.1M |
| Net Income | $22.0M | $22.0M | $21.2M | $27.8M |
| EBITDA | $58.7M | $58.7M | $70.7M | $90.7M |
| EPS | 0.05 | 0.05 | 0.04 | 0.05 |
| Gross Margin | 27.6% | 27.6% | 30.5% | 29.8% |
| Operating Margin | 3.0% | 3.0% | 6.1% | 8.7% |
| Net Margin | 4.7% | 4.7% | 4.3% | 5.3% |
| Balance Sheet | ||||
| Debt/Equity | 0.21 | 0.21 | 0.45 | 0.60 |
| Current Ratio | 2.40 | 2.40 | — | — |
| Cash Flow | ||||
| Free Cash Flow | $38.5M | $38.5M | $7.8M | $80.7M |
| Returns | ||||
| ROE | 7.3% | 7.3% | 11.2% | 15.7% |
| Valuation | ||||
| P/E | 92.00 | 92.00 | — | — |
| EV/EBITDA | 6.33 | 6.33 | — | — |
| P/B | 1.42 | 1.42 | — | — |
| Growth & Yield | ||||
| Revenue Growth | -6.0% | -6.0% | -6.6% | — |
| EPS Growth | 24.3% | 24.3% | -23.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
20.2%
EPS terminal req.
$0.08
Spread vs growth
4.0%
5Y implied EPS CAGR
16.0%
EPS terminal req.
$0.10
Spread vs growth
8.2%
10Y implied EPS CAGR
13.0%
EPS terminal req.
$0.16
Spread vs growth
11.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-56.6%
Start / end P/E
56.0x → 19.6x
EPS bridge
0.04 → 0.05
Residual
-15.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.